Trials / Completed
CompletedNCT01001091
AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 312 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of AL-38583 in the treatment of the signs of inflammation associated with allergic conjunctivitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AL-38583 ophthalmic solution | |
| DRUG | AL-38583 ophthalmic solution vehicle | Inactive ingredients used as a placebo comparator |
| DRUG | Dexamethasone ophthalmic suspension, 0.1% |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2009-10-23
- Last updated
- 2014-07-17
Source: ClinicalTrials.gov record NCT01001091. Inclusion in this directory is not an endorsement.